Latest long-term debt for NMTC: $73K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), NMTC shows a long-term debt of $73K. That compares with $180K in the prior-year period — down 58.2% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NMTC's long-term debt is now $73K (was $180K) — a 58.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroOne Medical Technologies is outperforming or lagging.
Tracking NMTC's long-term debt over time shows whether NeuroOne Medical Technologies is scaling, shrinking, or reshaping that part of the business. The current reading is $73K That compares with $180K in the prior-year period — down 58.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has NeuroOne Medical Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $73K) with ownership activity and broader fundamentals.